Laura Elizabeth Lansdowne
Managing Editor
As managing editor, Laura works closely with the editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She plays an active part in the general oversight and training of the in-house editorial team, as well as working directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.
Latest Content
Infographic
Exploring the Drug Discovery and Development Pipeline
Drug discovery and development can take up to 15 years and cost over $1 billion dollars. This infographic details the steps involved from conceptualization of a treatment to bringing it to market.
Article
脐Cord-Derived干细胞可以帮助那些with Heart Failure
Umbilical cord-derived stem cells could be the answer for patients with heart failure. A study published yesterday, indicates that cardiac muscle function and quality-of-life could be enhanced after treatment with this specific type of stem cell.
Article
Encouraging Step Towards a Potential Therapeutic Strategy for Asthma
Researchers have discovered a compound with the ability to induce long-lasting bronchorelaxation and prevent hyperreactivity in murine models of asthma.
Article
Could a Lipid be the Key to Treating Chronic Inflammatory Diseases?
The lipid, 10-nitro-oleic-acid, an endogenous nitro-fatty acid (NFA) modulator, is being explored as a treatment for chronic inflammatory diseases. Prof. Valerie O'Donnell's group was one of the few that originally identified the lipid’s ability to reduce inflammation.
Article
LipidFinder: An Open-Source Python Workflow for Novel Lipid Discovery
Researchers at the University of Cardiff, UK have developed a Python based computational workflow that is tailored to the analysis of large volumes of data, with the ability to identify novel lipids.
Industry Insight
Cell-based Imaging and Screening Applications
BioStatus develops and supplies products for cell-based imaging, cytometry and screening applications. We met with Roy Edward, Director at BioStatus during the High Content and Phenotypic Screening 2017 event to learn more.
Advertisement
